Neurallys, startup from the iPEPS-ICM incubator, will be attending the France Tech Transfer Invest 2018 as disruptive medtech company in the French ecosystem.
For this second tour, seven start-ups specialized in medical devices, biotech and e- health were selected by a judging panel of French and Israeli healthcare experts. They will receive dedicated support for a period of three months, including a one-week immersion workshop in Tel Aviv, Israel, from May 20 to 25, 2017.
In an initial round that took place in February, a group of 13 companies was chosen out of 24 startups and SMES that applied. They had the opportunity to pitch to a bilateral expert judging panel composed of healthcare experts, investors and representatives of innovation organizations from Paris and Boston, such as Brown Rudnick, Acceleration International and Bpifrance. In the second round eight companies were selected based on their innovative solutions, team expertise and business potential for the US market.
An interview of Neurallys can be read in the Entreprendre French Magazine of October 2016